000 | 01824 a2200529 4500 | ||
---|---|---|---|
005 | 20250515013902.0 | ||
264 | 0 | _c20060317 | |
008 | 200603s 0 0 eng d | ||
022 | _a0004-3591 | ||
024 | 7 |
_a10.1002/art.21620 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Dell, James R | |
245 | 0 | 0 |
_aTreatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. _h[electronic resource] |
260 |
_bArthritis and rheumatism _cFeb 2006 |
||
300 |
_a621-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDoxycycline _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Status |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetalloproteases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRheumatoid Factor _xblood |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aElliott, Jennifer R | |
700 | 1 | _aMallek, Jack A | |
700 | 1 | _aMikuls, Ted R | |
700 | 1 | _aWeaver, Cynthia A | |
700 | 1 | _aGlickstein, Scott | |
700 | 1 | _aBlakely, Kent M | |
700 | 1 | _aHausch, Raymond | |
700 | 1 | _aLeff, Rob D | |
773 | 0 |
_tArthritis and rheumatism _gvol. 54 _gno. 2 _gp. 621-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.21620 _zAvailable from publisher's website |
999 |
_c16061166 _d16061166 |